| MicroRNAs in development and disease AE Erson, EM Petty Clinical genetics 74 (4), 296-306, 2008 | 333 | 2008 |
| Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss IN Bespalova, G Van Camp, S JH Bom, DJ Brown, K Cryns, AT DeWan, ... Human molecular genetics 10 (22), 2501-2508, 2001 | 324 | 2001 |
| Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy NS Ozek, S Tuna, AE Erson-Bensan, F Severcan Analyst 135 (12), 3094-3102, 2010 | 129 | 2010 |
| Estrogen-induced upregulation and 3′-UTR shortening of CDC6 BH Akman, T Can, AE Erson-Bensan Nucleic acids research 40 (21), 10679-10688, 2012 | 106 | 2012 |
| USP32 regulates late endosomal transport and recycling through deubiquitylation of Rab7 A Sapmaz, I Berlin, E Bos, RH Wijdeven, H Janssen, R Konietzny, ... Nature communications 10 (1), 1454, 2019 | 80 | 2019 |
| USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers S Akhavantabasi, HB Akman, A Sapmaz, J Keller, EM Petty, AE Erson Mammalian genome 21, 388-397, 2010 | 76 | 2010 |
| miR-125b targets ARID3B in breast cancer cells S Akhavantabasi, A Sapmaz, S Tuna, AE Erson-Bensan Cell Structure and Function 37 (1), 27-38, 2012 | 72 | 2012 |
| 3′ UTR shortening and EGF signaling: implications for breast cancer HB Akman, M Oyken, T Tuncer, T Can, AE Erson-Bensan Human molecular genetics 24 (24), 6910-6920, 2015 | 70 | 2015 |
| Introduction to microRNAs in biological systems AE Erson-Bensan MiRNomics: MicroRNA biology and computational analysis, 1-14, 2014 | 70 | 2014 |
| m6A Modification and Implications for microRNAs AE Erson-Bensan, O Begik Microrna 6 (2), 97-101, 2017 | 66 | 2017 |
| Alternative Polyadenylation: Another Foe in Cancer AE Erson-Bensan, T Can Molecular Cancer Research 14 (6), 507-517, 2016 | 63 | 2016 |
| Virtual genome scan: a tool for restriction landmark-based scanning of the human genome JM Rouillard, AE Erson, R Kuick, J Asakawa, K Wimmer, M Muleris, ... Genome research 11 (8), 1453-1459, 2001 | 61 | 2001 |
| CHFR‐associated early G2/M checkpoint defects in breast cancer cells AE Erson, EM Petty Molecular Carcinogenesis: Published in cooperation with the University of …, 2004 | 51 | 2004 |
| An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions SD Selcuklu, MC Yakicier, AE Erson Cancer genetics and cytogenetics 189 (1), 15-23, 2009 | 49 | 2009 |
| miRNAs and cancer: New research developments and potential clinical applications AE Erson, EM Petty Cancer biology & therapy 8 (24), 2317-2322, 2009 | 48 | 2009 |
| Alternative polyadenylation and RNA-binding proteins AE Erson-Bensan Journal of Molecular Endocrinology 57 (2), F29-F34, 2016 | 45 | 2016 |
| Overexpressed Genes/ESTs and Characterization of Distinct Amplicons on 17q23 in Breast Cancer Cells AE Erson, BL Niell, SK DeMers, JM Rouillard, SM Hanash, EM Petty Neoplasia 3 (6), 521-526, 2001 | 31 | 2001 |
| Matrix metalloprotease 16 expression is downregulated by microRNA-146a in spontaneously differentiating Caco-2 cells. BS Astarci E, Erson-Bensan AE Dev Growth Differ. 54 (2), 216-26, 2012 | 27 | 2012 |
| Alternative polyadenylation and its impact on cellular processes H B. Akman, A E. Erson-Bensan Microrna 3 (1), 2-9, 2014 | 23 | 2014 |
| Molecular and genetic events in neoplastic transformation AE ERSON, EM PETTY Cancer Epidemiology and Prevention 4, 47-64, 2006 | 22 | 2006 |